vers la météo de la validation par utilisateur

Ingenuity256


precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 0 - PMID ?

In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :

Analyse 0
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 1
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 2
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 3
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 4
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 5
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 6
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 7
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 8
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 9
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 10
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 11
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 12
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 13
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 14
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 15
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 16
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 17
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 18
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 19
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 20
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 21
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 22
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 23
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 24
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 25
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 26
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 27
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 28
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 29
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 30
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 31
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 32
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 33
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 34
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 35
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 36
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 37
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 38
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 39
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 40
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 41
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 42
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 43
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 44
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 45
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 46
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 47
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 48
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 49
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 50
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 51
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 52
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 53
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 54
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 55
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 56
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 57
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 58
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 59
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 60
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 61
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 62
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 63
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 64
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 65
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 66
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 67
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 68
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 69
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 70
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 71
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 72
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 73
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 74
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 75
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 76
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 77
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 78
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 79
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 80
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 81
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 82
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 83
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 84
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 85
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 86
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 87
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 88
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 89
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 90
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 91
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 92
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 93
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 94
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 95
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 96
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 97
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 98
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 99
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 100
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 101
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 102
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 103
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 104
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 105
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 106
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 107
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 108
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 109
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 110
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 111
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 112
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 113
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 114
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 115
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 116
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 117
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 118
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 119
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 120
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 121
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 122
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 123
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 124
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 125
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 126
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 127
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 128
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 129
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 130
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 131
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 132
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 133
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 134
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 135
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 136
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 137
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 138
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 139
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 140
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 141
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 142
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 143
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 144
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 145
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 146
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 147
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 148
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 149
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 150
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 151
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 152
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 153
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 154
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 155
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 156
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 157
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 158
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 159
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 160
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 161
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 162
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 163
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                        +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 164
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 165
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 166
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 167
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 168
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 169
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 170
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 171
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |      +--------------------------------------------SUBJ:V-N-------------------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,miss)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 172
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 173
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 174
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 175
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 176
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 177
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 178
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 179
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 180
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 181
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 182
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 183
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 184
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 185
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 186
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 187
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                                                                 +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 188
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 189
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 190
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 191
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 192
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 193
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 194
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 195
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 196
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 197
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 198
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 199
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 200
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 201
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      |                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 202
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 203
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 204
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 205
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 206
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 207
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 208
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 209
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 210
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 211
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 212
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 213
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 214
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 215
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +--------SUBJ:V-N-------+                                         +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      +-COMP:N-N(from)-+      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,__SP__)
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,liver)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 216
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 217
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 218
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 219
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                       +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |                       +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 220
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 221
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 222
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 223
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+                                                                          
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                                    
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 224
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 225
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 226
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 227
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 228
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 229
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 230
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 231
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+SUBJ:V+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 232
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 233
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 234
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 235
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 236
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 237
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 238
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 239
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                +--------------------------------------------COMP:V-N(from)--------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                |                                                +-----------------------SUBJ:V-N----------------------+          +-------COMP:N-N(of)-------+                             |      
      |                |      +-----OBJ:V-N----+                        |                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          +MOD_A+      |         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (__SP__,male)
OBJ:V-N (miss,gland)
MOD_ATT:N-ADJ (gland,adrenal)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,__SP__)
SUBJ:V-N (decrease,administration)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 240
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 241
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 242
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 243
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 244
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 245
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 246
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 247
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 248
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 249
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 250
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 251
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 252
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 253
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 254
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                          
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 255
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                          
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 256
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 257
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 258
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                          
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 259
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                          
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 260
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 261
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 262
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 263
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +MOD_ATT:N-AD+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-ADJ (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 264
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 265
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 266
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 267
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 268
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 269
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 270
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 271
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+--------------------------COMP:V-N(after)--------------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:V-N(after) (decrease,treatment)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 272
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 273
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 274
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 275
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 276
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 277
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 278
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                          
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 279
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                          
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 280
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 281
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      +-----COMP:N-N(from)----+                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
COMP:N-N(from) (liver,miss)
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 282
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                          
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 283
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+                                                                          
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                                    
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+-------COMP:N-N(after)-------+      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(after) (mRNA,treatment)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 284
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 285
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)

Analyse 286
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-ADJ (treatment,initial)

Analyse 287
      +------------------------------------------------------COMP:V-N(In)-----------------------------------------------------+                                                                          
      |                       +-----------------------------------------COMP:V-N(from)----------------------------------------+          +---------------------COMP:N-N(after)--------------------+      
      |                       |                +-----------------------------------SUBJ:V-N-----------------------------------+          +-------COMP:N-N(of)-------+                             |      
      |          +-MOD_ATT:N-N+                +----------APPOS---------+                       +------OBJ:V-N------+         |          |           +-MOD_ATT:N-ADJ+                             |      
      |          |     +MOD_AT+         +MOD_AT+          +MOD_ATT:N-ADJ+-COMP:N-N(of)-+        |       +COMP:N-+   |         +--OBJ:V-N-+           |       +MOD_AT+   +MOD+MOD:A+      +MOD_ATT:+      
      |          |     |      |         |      |          |             |              |        |       |       |   |         |          |           |       |      |   |   |     |      |        |      
 In liver from male __SP__ missing a adrenal gland , intravenous administration of __NODE__ ( with a dosage of 50 mg/kg ) decreases expression of __SP__ __NODE__ mRNA 72 hours after initial treatment .
MOD_ATT:N-N (miss,male)
MOD_ATT:N-ADJ (miss,__SP__)
MOD_ATT:N-ADJ (gland,adrenal)
APPOS (gland,administration)
MOD_ATT:N-ADJ (administration,intravenous)
COMP:N-N(of) (administration,__NODE__)
OBJ:V-N (with,mg/kg)
COMP:N-N(of) (dosage,@card@)
COMP:V-N(In) (decrease,liver)
COMP:V-N(from) (decrease,miss)
SUBJ:V-N (decrease,gland)
OBJ:V-N (decrease,expression)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(after) (expression,treatment)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-ADJ (hour,@card@)
MOD:ADV-N (after,hour)
MOD_ATT:N-N (treatment,initial)